Dep. of Obstetrics and Gynecology, Bern University Hospital, Bern
Bern, 3010, Switzerland
Location status: Recruiting
Location contact
Lara Schmid, study nurse
CONTACT
Petra Stute, M.D.
PRINCIPAL_INVESTIGATOR
Petra Stute, MD
CONTACT
NCT Number: NCT04705623
The purpose of this Study is to find out if Iyengar-Yoga has a rejuvenating effect on women after menopause. The biofunctional status of the study participants will be assessed before and after a 12-week yoga program.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Bern, 3010, Switzerland
Location status: Recruiting
Lara Schmid, study nurse
CONTACT
Petra Stute, M.D.
PRINCIPAL_INVESTIGATOR
Petra Stute, MD
CONTACT
Postmenopausal women qualifying as participants for the study are patients at the Universitätsklinik für Frauenheilkunde in Bern or are recruited through public advertisement. After giving informed consent the patients will be screened for inclusion and exclusion criteria and their biofunctional Status will be assessed. The participants of the study will then be randomly assigned to the intervention group (12 week yoga program) or to the control group. In addition to the 90 minutes yoga sessions instructed by a professional yoga teacher, the participants of the intervention group are asked to perform two yoga sessions lasting 45 minutes per week at home and document these in a diary.
After the 12 weeks the biofunctional Status of all participants of the study will be reassessed.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Weekly 90 minute Iyengar Yoga classes taught y a professional instructor. Twice weekly 45 minute self practice of Iyengar Yoga at home by the participants
Time frame: 12 weeks
The BFS is a generic, age- and sex-specific test battery comprising holistic characteristics from physical, mental-emotional and social areas. The single values of the BFS test battery were scaled and differentiated for chronological age (CA) and sex. Their summation makes up the so-called Bio-functional Age Index BFAI (BFAI = Σ (B-X/B-L)n/n). The BFAI is a relative measure compared to a reference population, out of which norm charts were developed. By definition, the reference population's BFAI is identical with its CA. A BFAI of an individual may be transformed into BFA (years) by means of gerontologic aging tables. This BFA (years) relates to the mean value of a certain CA. The BFA is based on a sex-specific regression and factor analysis of functional age (Mathieu et al., 2018. Illness perception in overweight and obesity and impact on bio-functional age. Archives of gynecology and obstetrics, 298(2), p. 417)
Time frame: 12 weeks
Change of the climacteric symptom hot flushes (number per day) measured at the beginning and after 12 weeks of the intervention
Time frame: 12 weeks
Change of the climacteric symptom Level of HS-CRP (mg/l) measured at the beginning and after 12 weeks of the intervention
Time frame: 12 weeks
Change of the climacteric symptom oxidative balance measured at the beginning and after 12 weeks of the intervention
Contact information is provided by the study sponsor or research team.
Natascha Rieben, Study Nurse
CONTACT
Petra o Stute, Prof. Dr. med
CONTACT
Insel Gruppe AG, University Hospital Bern
Other
A Single-center, Randomized, Controlled, Open-labelled, Two-armed, Interventional Clinical Trial Investigating the Effect of a 12 Week Iyengar Yoga Intervention on the Bio-functional Age of Postmenopausal Women.
Acronym: IIYBFAPW
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07377383
Cardiovascular Diseases, Hypertension
Oleiros, A Coruña, Spain
View Trial DetailsNCT06445842
Postmenopausal
Loma Linda, California, United States
View Trial DetailsNCT07615790
Autonomic Nervous System Diseases, Dyssomnias
Istanbul, Atasehir, Turkey (Türkiye)
View Trial DetailsNCT07131215
Menopause, Postmenopausal
Tainan, Taiwan
View Trial Details